Veeva Systems (NYSE:VEEV) Updates Q3 2027 Earnings Guidance

Veeva Systems (NYSE:VEEV) issued an update on its third quarter 2027 earnings guidance on Wednesday. The company provided earnings per share guidance of 2.330-2.340 for the period, compared to the consensus estimate of 2.160. The company issued revenue guidance of $932.0 million-$935.0 million, compared to the consensus revenue estimate of $917.9 million. Veeva Systems also updated its FY 2027 guidance to 9.210-9.210 EPS.

Veeva Systems Trading Down 0.8%

Shares of VEEV traded down $2.06 during trading hours on Wednesday, reaching $244.72. 1,444,137 shares of the company’s stock traded hands, compared to its average volume of 2,454,633. The stock has a market cap of $39.75 billion, a PE ratio of 43.62, a price-to-earnings-growth ratio of 1.07 and a beta of 0.92. The firm’s 50 day simple moving average is $201.60 and its 200-day simple moving average is $182.61. Veeva Systems has a 12 month low of $148.05 and a 12 month high of $310.50.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.10. The company had revenue of $882.95 million for the quarter, compared to analysts’ expectations of $857.73 million. Veeva Systems had a net margin of 28.37% and a return on equity of 13.72%. Veeva Systems’s revenue for the quarter was up 16.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.97 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, analysts expect that Veeva Systems will post 6.64 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Wall Street Zen lowered shares of Veeva Systems from a “buy” rating to a “hold” rating in a report on Monday, August 3rd. Robert W. Baird upped their target price on shares of Veeva Systems from $250.00 to $260.00 and gave the stock an “outperform” rating in a research report on Thursday, June 4th. Royal Bank Of Canada reissued an “outperform” rating and issued a $275.00 target price on shares of Veeva Systems in a research note on Thursday, June 4th. BTIG Research restated a “buy” rating and set a $340.00 price target on shares of Veeva Systems in a research report on Thursday, June 4th. Finally, Guggenheim lifted their price target on Veeva Systems from $232.00 to $276.00 and gave the stock a “buy” rating in a research note on Thursday, August 20th. Nineteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Veeva Systems has a consensus rating of “Moderate Buy” and a consensus target price of $258.08.

Insider Activity

In other news, insider Thomas D. Schwenger sold 36,000 shares of the company’s stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $250.23, for a total value of $9,008,280.00. Following the completion of the sale, the insider owned 19,449 shares of the company’s stock, valued at approximately $4,866,723.27. This represents a 64.92% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 10.60% of the company’s stock.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Major customer wins strengthen Vault CRM adoption. Biogen and Regeneron both committed to Veeva Vault CRM globally. The agreements support Veeva’s position in life-sciences commercial software and could contribute to future subscription growth. Veeva Vault CRM Selected by Biogen Veeva Vault CRM Selected by Regeneron
• Positive Sentiment: Truist said the wins reinforce Veeva’s market leadership. The bank characterized Vault CRM as the clear leader in life-sciences CRM ahead of earnings, providing a favorable read-through on competitive positioning and demand. Veeva’s Vault CRM Wins Reinforce Market-Leader Status Ahead of Earnings
• Positive Sentiment: Needham reaffirmed its “Buy” rating. The repeated bullish recommendation adds support to the investment case as investors assess Veeva’s growth prospects and valuation. Needham Reaffirms Buy Rating
• Neutral Sentiment: Piper Sandler initiated coverage. New analyst coverage may increase institutional attention, although the article does not specify the firm’s rating or price target. Veeva Coverage Initiated at Piper Sandler
• Neutral Sentiment: Earnings remain the near-term catalyst. Veeva is scheduled to report second-quarter results after the bell. Its previous quarter exceeded consensus estimates, with revenue up 16.3% year over year, so investors will focus on results, subscription growth, and forward guidance. What to Expect From Veeva Systems’s Q2 Earnings

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Measured Wealth Private Client Group LLC bought a new stake in shares of Veeva Systems in the 3rd quarter valued at about $45,000. J.Safra Asset Management Corp grew its position in Veeva Systems by 2,940.0% during the 4th quarter. J.Safra Asset Management Corp now owns 152 shares of the technology company’s stock worth $34,000 after acquiring an additional 147 shares during the last quarter. Raiffeisen Bank International AG increased its stake in Veeva Systems by 59.8% in the 4th quarter. Raiffeisen Bank International AG now owns 155 shares of the technology company’s stock worth $35,000 after purchasing an additional 58 shares during the period. Rakuten Securities Inc. increased its stake in Veeva Systems by 56.7% in the 2nd quarter. Rakuten Securities Inc. now owns 163 shares of the technology company’s stock worth $47,000 after purchasing an additional 59 shares during the period. Finally, Palisade Asset Management LLC bought a new stake in Veeva Systems in the third quarter valued at approximately $66,000. Hedge funds and other institutional investors own 88.20% of the company’s stock.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.